Lipid nanoparticle delivery of TALEN mRNA targeting LPA causes gene disruption and plasma lipoprotein(a) reduction in transgenic mice
2024 · Molecular Therapy · 9 citations
https://doi.org/10.1016/j.ymthe.2024.11.020
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
11
Citations
1
h-index
1
i10-index
Linda Quirino is an academic researcher from Arcturus Therapeutics (United States). The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Viral Infections and Immunology Research & Biosimilars and Bioanalytical Methods. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat